{"schema_version":"1","generated_at":"2026-10-28T11:21:47.004Z","data_as_of":null,"url":"https://www.findmykol.com/kol/donald-yee","json_url":"https://www.findmykol.com/kol/donald-yee/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"donald-yee","name":"Donald Yee","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1790865046","openalex":"A5073290209"},"summary":"Donald Yee is an Oncology physician. OpenAlex indexes 79 publications with 1,975 citations (h-index 24).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":79,"cited_by_count":1975,"h_index":24,"latest_activity_year":2025,"source":"works"},"funding":{"award_count":1,"fiscal_years":{"first":2005,"last":2008},"rows_total":4,"shown":3,"withheld":1,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"K23HL081539","title":"Platelets as Modifiers of Phenotype in Hemophilia A","fiscal_year":2008,"amount_usd":"155333","organization":"BAYLOR COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/K23HL081539"},{"project":"K23HL081539","title":"Platelets as Modifiers of Phenotype in Hemophilia A","fiscal_year":2007,"amount_usd":"155333","organization":"BAYLOR COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/K23HL081539"},{"project":"K23HL081539","title":"Platelets as Modifiers of Phenotype in Hemophilia A","fiscal_year":2006,"amount_usd":"155333","organization":"BAYLOR COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/K23HL081539"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 study","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2024014907","status":"verified"},{"title":"Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study","year":2023,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2023010840","status":"verified"},{"title":"Preliminary Findings of a Phase Ib/II Trial Indicate Manageable Safety and Promising Efficacy for Mosunetuzumab in Combination with Lenalidomide (M+Len) in Previously Untreated (1L) Follicular Lymphoma (FL)","year":2023,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2023-174432","status":"verified"},{"title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial","year":2019,"journal":"The Lancet Haematology","source_url":"https://doi.org/10.1016/s2352-3026(19)30219-4","status":"verified"},{"title":"Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies","year":2019,"journal":"The Lancet Haematology","source_url":"https://doi.org/10.1016/s2352-3026(19)30161-9","status":"verified"}],"source":"works"},"contact":{"address_1":"6701 FANNIN ST","city":"Houston","state":"TX","zip":"770302316","phone":"832-822-4240","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1790865046","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":1,"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2011-08-18","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}